comparemela.com

A real-world study from Spain suggests baricitinib demonstrated favorable effectiveness, adherence, and safety in rheumatoid arthritis, but investigators caution more research is needed.







Related Keywords

Madrid ,Spain ,Rosario Garc ,Linkedin Rosario Garc ,Autonomous University Of Madrid ,Princesa University Hospital ,Drug Administration ,Autonomous University ,Disease Activity Score ,Compliance Questionnaire ,Standard Deviation ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.